We are live on
!
Find out more
Rockefeller Capital Management Portfolio holdings
AUM
$56.4B
1-Year Est. Return
24.96%
This Fund
S&P 500
This Quarter
Est. Return
-0.57%
1 Year Est. Return
+24.96%
3 Year Est. Return
+83.53%
5 Year Est. Return
+100.91%
10 Year Est. Return
–
AUM
$19B
AUM Growth
+$1.28B
(+7.2%)
Cap. Flow
+$1.55B
Cap. Flow
% of AUM
8.12%
Top 10 Holdings %
Top 10 Hldgs %
20.03%
Holding
3,992
New
448
Increased
1,821
Reduced
816
Closed
180
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Elanco Animal Health
ELAN
|
+$89.1M |
| 2 |
WEX
WEX
|
+$78.4M |
| 3 |
Blackrock
BLK
|
+$73.2M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$71.9M |
| 5 |
OneMain Financial
OMF
|
+$45.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$63.6M |
| 2 |
Neurocrine Biosciences
NBIX
|
+$56.6M |
| 3 |
Agnico Eagle Mines
AEM
|
+$55.1M |
| 4 |
DFS
Discover Financial Services
DFS
|
+$36M |
| 5 |
ORBC
ORBCOMM, Inc.
ORBC
|
+$27.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.39% |
| 2 | Financials | 14.65% |
| 3 | Healthcare | 12.11% |
| 4 | Consumer Discretionary | 7.54% |
| 5 | Industrials | 6.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RFMZ
526
RiverNorth Flexible Municipal Income Fund II
RFMZ
$322M
| $4.15M | 0.02% |
205,020
+101,094
| +97% | +$2.13M |
|
527
Valero Energy
VLO
$85.9B
| $4.14M | 0.02% |
58,668
+1,294
| +2% | +$86.1K |
|
528
First Trust Rising Dividend Achievers ETF
RDVY
$25.6B
| $4.13M | 0.02% |
87,084
-1,300
| -1% | -$63K |
|
529
SolarEdge
SEDG
$1.95B
| $4.11M | 0.02% |
15,504
+11,003
| +244% | +$3M |
|
530
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$14.7B
| $4.11M | 0.02% |
37,352
+1,123
| +3% | +$126K |
|
531
Duke Energy
DUK
$97.3B
| $4.11M | 0.02% |
42,091
+7,150
| +20% | +$740K |
|
532
Trade Desk
TTD
$6.49B
| $4.11M | 0.02% |
58,433
-1,486
| -2% | -$115K |
|
533
State Street SPDR Portfolio S&P 500 Value ETF
SPYV
$36.8B
| $4.1M | 0.02% |
105,205
-1,549
| -1% | -$61.9K |
|
534
West Pharmaceutical
WST
$24.9B
| $4.1M | 0.02% |
9,662
+2,674
| +38% | +$1.13M |
|
535
First Trust NASDAQ-100 Technology Index Fund
QTEC
$4.83B
| $4.1M | 0.02% |
25,966
+13,314
| +105% | +$2.16M |
|
536
Invesco S&P 500 Low Volatility ETF
SPLV
$7.21B
| $4.09M | 0.02% |
67,242
+24,942
| +59% | +$1.57M |
|
537
McKesson
MCK
$101B
| $4.08M | 0.02% |
20,474
+570
| +3% | +$114K |
|
538
Darling Ingredients
DAR
$9.44B
| $4.08M | 0.02% |
+56,725
| New | +$4.06M |
|
539
International Paper
IP
$22B
| $4.08M | 0.02% |
76,978
+9,174
| +14% | +$511K |
|
|
BXMX
540
DELISTED
Nuveen S&P 500 Buy-Write Income Fund
BXMX
| $4.07M | 0.02% |
285,789
+47,127
| +20% | +$691K |
|
541
KB Financial Group
KB
$43.5B
| $4.06M | 0.02% |
87,459
+1,571
| +2% | +$71K |
|
542
First Trust Industrials/Producer Durables AlphaDEX Fund
FXR
$766M
| $4.05M | 0.02% |
70,588
+35,965
| +104% | +$2.14M |
|
543
SLB Ltd
SLB
$75B
| $4.04M | 0.02% |
136,504
-3,144
| -2% | -$90.1K |
|
544
iShares US Technology ETF
IYW
$25.2B
| $4M | 0.02% |
39,548
+340
| +0.9% | +$35.5K |
|
545
Golub Capital BDC
GBDC
$3.42B
| $4M | 0.02% |
253,048
+38,806
| +18% | +$610K |
|
546
Baidu
BIDU
$37.2B
| $3.99M | 0.02% |
25,956
+4,343
| +20% | +$713K |
|
|
MAXR
547
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
| $3.99M | 0.02% |
140,896
+29,092
| +26% | +$934K |
|
548
iShares GNMA Bond ETF
GNMA
$423M
| $3.93M | 0.02% |
78,693
+21,102
| +37% | +$1.06M |
|
549
Vanguard FTSE Pacific ETF
VPL
$8.43B
| $3.91M | 0.02% |
48,227
-62
| -0.1% | -$5.12K |
|
|
UFOX
550
Defiance Space and Connective Tech ETF
UFOX
$911M
| $3.9M | 0.02% |
107,540
+23,413
| +28% | +$886K |
|
Similar funds
NAMI
Rockefeller Capital Management's Q3 2021 Portfolio in Review
As of Q3 2021, Rockefeller Capital Management held 3,992 positions worth $19B, up 7.2% from $17.8B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Rockefeller Capital Management deployed $1.55B of net new capital in Q3 2021, opening 448 new positions and adding to 1,821 existing holdings. Its largest new stake was Darling Ingredients: 56,725 shares worth $4.08M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Regeneron Pharmaceuticals, an estimated $63.6M trimmed.
- Rockefeller Capital Management's largest Q3 2021 buy was Darling Ingredients: 56,725 shares worth $4.08M.
- Rockefeller Capital Management added most to Elanco Animal Health in Q3 2021, an estimated $89.1M increase.
- Rockefeller Capital Management's biggest Q3 2021 reduction was Regeneron Pharmaceuticals, cutting an estimated $63.6M.
- Rockefeller Capital Management fully exited ORBCOMM, Inc. in Q3 2021, selling an estimated $27.5M.
- Rockefeller Capital Management's ten largest holdings make up 20% of its $19B portfolio in Q3 2021.
- Rockefeller Capital Management opened 448 new positions and closed 180 in Q3 2021.
- Rockefeller Capital Management's portfolio value rose 7.2% quarter-over-quarter to $19B.
Based on Rockefeller Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.